SMMARUN Contact us
Home / Industry / Pharmaceutical

Provenance becomes the product.

Provenance and AI speed, evidenced together. Indian pharma faces unique IP and patient-safety exposure across discovery, trials and pharmacovigilance. SMMARUN turns that exposure into a single operating discipline.

Where we work

Four governance domains. One operating posture.

i.

AI in drug discovery

Model risk and reproducibility for AI in target validation, lead optimisation, and assay-design support. The reasoning trace is part of the lab notebook, not a sidecar.

  • Reproducibility frameworks for discovery AI
  • Knowledge-graph retrieval with citation discipline
  • Reasoning-trace as primary record
ii.

Clinical-trial AI governance

Bias, consent, audit. Trial-data hygiene with row-level lineage. Every classification reversible on an auditor's clock.

  • Trial-data hygiene with row-level lineage
  • Bias monitoring across population strata
  • Consent flow built into the system
iii.

Pharmacovigilance AI

Adverse-event signal detection, AI-driven causality assessment, ICSR triage with reversible classification. Built so a regulator can reconstruct the AI's contribution to any decision, in writing, at any later date.

  • ICSR triage with reversible classification
  • Signal detection across MedDRA hierarchies
  • Audit-ready provenance ledgers
iv.

FDA / CE compliance

AI-enabled tools for regulatory drafting, CMC submissions, and software-as-a-medical-device. Export-ready governance from prototype, classification mapping aligned to the strictest market.

  • CMC submission copilots, agency-aligned
  • Software-as-a-medical-device classification
  • Deficiency-letter response automation
The Defensible AI Equation

Three services. One discipline. Defensible AI in pharmaceutical.

AI Governance, Fairness & Risk Management

Provenance and export controls.

AI-assisted drug discovery generates IP that crosses borders. Provenance controls held against ICMR, FDA, CE, CDSCO, PvPI and DPDPA. Pharmacovigilance and clinical trial integrity, evidenced under audit.

Read more →

Your AI investments in research, manufacturing, and pharmacovigilance deliver returns because the controls hold while the system moves. The estate is held against ICMR, FDA / CE, CDSCO, PvPI and DPDPA as one operating posture.

  • DPDPA readiness, operationalised
  • ICMR alignment for AI in biomedical research
  • CDSCO Draft SaMD readiness for AI-enabled medical devices
  • FDA / CE compliance for AI-assisted drug discovery export
  • PvPI causality assessment, evidenced under audit
  • Use-case registries with named accountability
  • ByteVerity deterministic evidence substrate integrated
Masterclass in AI Governance

Research leadership literacy.

Research leaders need vocabulary the regulator recognises. Governance committees capable of holding the line when AI-generated evidence enters a submission. Calibrated for principal investigators, programme leads and board sponsors in turn.

Read more →

Calibrated for principal investigators, research leadership, regulatory affairs, and board sponsors in turn. Curriculum anchored to ISO 42001, NIST AI RMF, ICH GCP, and the India regulatory stack. Co-branded certification with premier academic institutions.

  • ExecClass for boards and CXOs
  • Three-day intensive for research and regulatory leadership
  • Cohort-based, peer-to-peer, on-the-record
  • Curriculum anchored to ISO 42001, NIST AI RMF, ICH GCP, and the India regulatory stack
  • Shrink-wrapped, Tailor-Made, or Hybrid delivery
  • Co-branded certification with premier academic institutions
Digital Risk Governance Platforms

Mandatory-coverage proofs and orchestration.

ByteVerity's Kernel and Vault planes deliver mandatory-coverage proofs for clinical data. Compilable stubs prevent IP leakage to offshore teams. EvoluteIQ automates supply chain and pharmacovigilance with full audit trace.

Read more →

EvoluteIQ's enterprise automation scales pharmacovigilance and supply chain workflows with guardrails encoded as policy. ByteVerity's Kernel and Vault planes prevent IP leakage on AI-assisted drug discovery and deliver mandatory-coverage proofs for clinical data. Full audit trace on every orchestration step.

  • ByteVerity: signed, un-tamperable evidence of every AI execution
  • EvoluteIQ: enterprise automation, Gartner MQ RPA 2025, 3,000+ connectors
  • Compilable stubs preventing IP leakage to offshore teams
  • Mandatory-coverage proofs for clinical data sources
  • Full audit trace on every orchestration step
  • Sector-specific guardrails encoded as policy from start
AI Governance + AI Master Class + Digital Risk Platforms = Defensible AI
How we engage

Twelve weeks. Three phases. One practice that does not separate the platform from the people who run it.

i. Weeks 1–4

Assess

Audit your AI estate against ICMR, FDA / CE, DPDPA, and CDSCO. Surface the three highest-consequence agents and the three governance gates that must hold first. The output is a register of named risks, prioritised by consequence.

ii. Weeks 5–8

Implement

EvoluteIQ stood up with pharma-specific guardrails (provenance, reproducibility, consent, bias) encoded as policy. Two pilot agents move from intake to production with full audit trace, on a path the regulator could follow.

iii. Weeks 9–12

Embed

Governance committee operationalised, model owners named, R&D and pharmacovigilance roles re-cut for an AI-enabled operating model. The SMMARUN masterclass curriculum delivered. You leave operating the practice, not waiting on the platform.

Compliance scope
ICMRFDA / CEDPDPACDSCO Draft SaMDPvPIICH GCP
Begin a conversation

Begin a conversation about your pharma AI governance.